Calithera Biosciences, Inc. (CALA) Social Stream



Calithera Biosciences, Inc. (CALA): $0.02

0.00 (0.00%)

POWR Rating

Component Grades

Momentum

F

Stability

F

Sentiment

Quality

C

Add CALA to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#68 of 380

in industry

CALITHERA BIOSCIENCES INC (CALA) Price Targets From Analysts

Use the tables below to see what analysts covering CALITHERA BIOSCIENCES INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-12 4 $1.5 $1 $1.25 $0.03 4066.67%
2022-01-20 4 $3 $1.5 $2.25 $0.03 7400%
2022-02-09 4 $4 $1.5 $2.833 $0.03 9343.33%
2022-04-01 4 $3 $1.5 $2.5 $0.03 8233.33%
2022-05-10 4 $3 $1.5 $2.166 $0.03 7120%
2022-05-11 4 $40 $30 $33.333 $0.03 111010%
2022-08-16 4 $30 $18 $26 $0.03 86566.67%
2022-08-18 4 $30 $17 $21.666 $0.03 72120%
2022-08-29 4 $30 $8 $18.25 $0.03 60733.33%
2022-11-15 4 $18 $8 $13 $0.03 43233.33%
NA 1 $NA $NA $NA $0.03 NA%

The Trend in the Analyst Price Target


CALA's average price target has moved up $8 over the prior 21 months.

500 - Internal server error

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential

CALA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2 2 0 2 0 0 4

The Trend in the Broker Recommendations


CALA's average broker recommendation rating worsened by 0.33 over the prior 43 weeks.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CALA as an investment opportunity.

  • In terms of how CALITHERA BIOSCIENCES INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 1797.27% of that group.
  • CALA has a greater number of analysts covering the stock than 218.04% of all US stocks.
  • CALA has a higher average analyst price target than 452.26% of stocks in the small market cap category.
  • In terms of how CALITHERA BIOSCIENCES INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -594.46% of that group.

Stocks similar to CALITHERA BIOSCIENCES INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are RLMD, NEPT, and AGLE.

Is CALA a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!